Parvovirus B19 (B19V) is a human pathogenic virus, responsible for an ample range of
clinical manifestations. Infections are usually mild, self-limiting, and controlled by the …

Genetic analysis of parvovirus B19 has been carried out mainly to establish a framework to
track molecular epidemiology of the virus and to correlate sequence variability with different …

Abstract Human parvovirus B19 (B19V) is a major human pathogen causing a variety of
diseases, characterized by a selective tropism to human progenitor cells in bone marrow. In …

The pathogenic Parvovirus B19 (B19V) is characterized by a strict adaptation to erythroid
progenitor cells (EPCs), a heterogeneous population of differentiating cells with diverse …

A real‐time PCR assay was developed for quantitative detection of B19 DNA in clinical
serum samples. The assay was carried out using a LightCycler instrument and product …

Abstract Parvovirus B19 (B19V) is a human ssDNA virus responsible for a wide range of
clinical manifestations, still lacking for a specific antiviral therapy. The identification of …

Abstract Parvovirus B19 (B19V) infection is restricted to erythroid progenitor cells (EPCs) of
the human bone marrow, leading to transient arrest of erythropoiesis and severe …

The immune response against parvovirus B19 is mainly directed against the two structural
proteins, VP1 and VP2. The amino terminal half of the VP1 unique region has been shown …

Mesenchymal stromal/stem cells (MSCs) are multipotent cells with differentiation,
immunoregulatory and regenerative properties. Because of these features, they represent …

The IgM immune response against conformational and linear epitopes of B19 structural
proteins VP1 and VP2 was examined in serum samples with a suspect B19 infection to …